- Dec 19, 2025
Brain Fingerprints and the Future of Personalized Care
- Brendan Parsons, Ph.D., BCN
- Neurofeedback, Neuroscience
A July 2025 perspective in IEEE Signal Processing Magazine reframes a familiar neuroscience problem—people differ—as an opportunity rather than a nuisance. Instead of averaging brains into a single “typical” pattern, brain fingerprinting asks a more personal question: what makes your brain network organization reliably you across time?
The idea borrows from classic biometrics (like fingertip ridges), but swaps skin for networks: patterns of functional connectivity that link brain regions into dynamic coalitions. The authors describe how early work showed that individuals can be matched across scanning sessions using their functional connectome, with strikingly high identification rates in resting-state data and meaningful accuracy even during tasks. This pushes against a long-standing habit in neuroimaging: treating interindividual differences as statistical “error bars” rather than part of the phenomenon.
Clinically, that shift matters. Many diagnoses (and many treatment decisions) still rely on group-level patterns—yet the person in front of you is not an average. Brain fingerprints offer a framework for parsing what is trait-like (stable signatures), what is state-like (context-driven fluctuations), and what is degenerative (progressive erosion or reconfiguration of uniqueness).
This is also why fingerprinting is a natural conceptual bridge to biofeedback and neurofeedback. Neurofeedback is a training method that provides real-time information about brain activity (often via EEG) so the nervous system can learn self-regulation; biofeedback extends that same learning loop to other physiology (such as heart rate variability or electrodermal activity). In both cases, outcomes improve when targets are chosen with respect for individuality—because training the “average brain” is like prescribing the “average shoe size.”
Methods
This article is a methodological review/perspective rather than a single clinical trial, so its “methods” are best understood as the core pipeline used across brain fingerprinting studies.
The canonical approach begins with functional imaging time series, most often fMRI blood-oxygen-level-dependent (BOLD) signals, but also EEG and MEG in more recent work. Data are preprocessed to reduce nuisance influences (motion, physiological and scanner-related signals) and then parcellated into N brain regions. From these regional time courses, a functional connectome is computed: an N × N matrix of pairwise correlations that summarizes how strongly regions co-fluctuate.
To “fingerprint” a person, studies typically use two sessions (a test/retest design, often conceptualized as day 1 and day 2). Each connectome is vectorized by unfolding its upper triangle into a feature vector. Similarity between vectors (most commonly Pearson correlation, sometimes cosine or Euclidean distance) is computed across all subject pairs and stored in an identifiability matrix. The simplest classifier is nearest-neighbor matching: a person’s retest connectome is assigned to whichever test connectome is most similar.
Two methodological refinements stand out.
First, performance is not limited to raw accuracy. The authors describe “differential identifiability,” which quantifies separation between within-person similarity (diagonal elements) and between-person similarity (off-diagonals). This matters because a system can be accurate in a small sample yet poorly separated in a realistic cohort.
Second, fingerprints can be strengthened through denoising and reliability tools. Dimensionality reduction (SVD/PCA) can reconstruct connectomes using only components that maximize identifiability, while intraclass correlation (ICC) can highlight which connections are stable across sessions and therefore most informative. The review also explores geometry-aware approaches (treating correlation matrices as living on a curved manifold), including geodesic distances and tangent-space projections, plus machine learning classifiers (e.g., linear discriminant analysis and support vector machines) to move beyond simple matching.
Results
Because this is a perspective, the “results” are a synthesis of what the fingerprinting literature consistently finds.
First, fingerprints work—often surprisingly well. Foundational demonstrations showed that individuals can be identified across sessions using functional connectivity patterns, with very high performance in resting-state and solid performance across task contexts. Subsequent work supports that these signatures can remain stable over long periods, suggesting that some aspects of network organization are trait-like.
Second, not all connections contribute equally. Reliability analyses using ICC frequently point toward higher-order cognitive systems—such as default-mode and frontoparietal networks—as especially informative for identifiability during rest, with task demands shifting which regions carry the strongest fingerprint signal. This helps explain an everyday observation: you are most recognizably “you” when you are thinking in the ways you habitually think.
Third, denoising and better metrics improve fingerprints. SVD/PCA approaches can increase differential identifiability by down-weighting components that capture scanner noise, physiological artifacts, or other non-informative variance. Geometry-aware distances and tangent-space features can boost identifiability in some conditions (particularly tasks), though the review notes these methods can be more sensitive to noise and require careful regularization.
Fourth, fingerprints are not exclusive to fMRI. EEG and MEG can produce person-specific signatures as well, sometimes with stronger links to behavior and clinical features. Frequency-specific information appears especially relevant: alpha and beta connectivity often carry strong differentiating power, and even simpler spectral features (including aperiodic components) can help separate individuals.
Finally, fingerprints change in meaningful ways across states and disorders. Task engagement can enhance identifiability; anesthesia appears to reduce uniqueness; psychedelic states have been reported to increase intersubject dissimilarity. Clinically, reduced identifiability has been linked to neurodegenerative and neurological conditions in some studies, while other conditions may show different patterns (including potentially increased idiosyncrasy).
Discussion
If the traditional neuroimaging mindset is “find what the average brain does,” brain fingerprinting asks, “what does this brain reliably do, and when does it stop doing it?” That subtle shift has big practical consequences.
In everyday clinical work, we constantly juggle two types of information: stable traits and fluctuating states. A fingerprint framework formalizes that juggling. It also offers a way to track whether a change is an improvement, a compensation, or a collapse into a more stereotyped pattern. In other words, it can help disentangle idiosyncratic from degenerative signatures—an issue the authors highlight as central for translating fingerprints into health care.
The most immediate value may be precision monitoring rather than diagnosis. Many interventions—psychotherapy, medication trials, rehabilitation, neurofeedback—aim to shift patterns over time. Fingerprints provide quantitative handles on stability and drift: which connections remain reliable within a person, which become noisy, and which reorganize under stress, sleep loss, or treatment.
For people exploring self-regulation approaches, the message is both empowering and grounding: your brain has stable signatures, but it also has flexibility. Biofeedback and neurofeedback can be thought of as “guided practice” for the nervous system, where feedback nudges attention toward internal signals that are normally implicit. A fingerprint lens helps set realistic expectations: some traits may be slow to shift, while state-like patterns may change quickly but need repetition to become durable.
For clinicians and referring professionals, fingerprints hint at a future where treatment planning is less about matching a diagnosis to a protocol and more about matching a person’s neurophysiology to a strategy. The review also makes clear why standardization remains hard: fingerprint performance depends on acquisition and preprocessing choices, sample size, and measurement noise. That’s not a reason to dismiss the approach—it’s a reason to design clinics and studies that respect measurement science.
For neurofeedback professionals, several practical implications stand out. First, if higher-order networks tend to carry stable identifiability, then protocols that influence large-scale regulation (arousal, attentional control, network switching) may have downstream effects that matter beyond a single band or site. Second, the strength of EEG/MEG fingerprinting in alpha and beta ranges is a reminder that training in these frequencies often touches trait-like control systems: alpha rhythms are deeply tied to inhibitory gating and internal attention, while beta rhythms are tied to maintenance of sensorimotor and cognitive sets. Third, the temporality work suggests that brief “bursts” of identifiable patterns can exist within shorter windows—an intriguing parallel to clinical sessions where moments of clear regulation suddenly appear before they stabilize into a habit.
A final interpretive thread runs through the whole review: identity is not a single number. It is a pattern that can be stable, context-sensitive, and biologically constrained all at once. The more we build tools that respect that complexity—rather than flatten it into an average—the more plausible it becomes to deliver truly personalized interventions.
Brendan’s perspective
Brain fingerprinting has a way of making clinicians simultaneously excited and slightly uneasy: excited because it validates what we see every day (people are not averages), and uneasy because it raises a hard question—if every nervous system is distinct, why do we keep pretending one-size-fits-most protocols are “personalized” just because we picked a diagnosis label?
Here’s the utility I see, especially for neurofeedback: fingerprinting can become a bridge between assessment and action. In qEEG practice, we already do a version of this with spectral patterns, asymmetries, coherence, phase relationships, and even aperiodic features that hint at excitation–inhibition balance. But the leap from “interesting map” to “good training plan” is where the field still gets wobbly. Fingerprinting offers a more disciplined way to ask: which features of this person are stable enough to trust as targets, and which are momentary states that will evaporate the minute they sleep better, drink less caffeine, or stop bracing their jaw during the recording?
Protocol selection can improve when we separate three layers.
First is the core signature: the parts of a person’s EEG that are reliably them across days and contexts. This might include a consistent peak alpha frequency, a stable topography of alpha power, a repeating pattern of fronto-parietal connectivity in beta, or a characteristic aperiodic slope. These are the elements I treat as the “load-bearing walls” of the nervous system. When they are clearly stable, they can guide where to train. For example, a client with a consistently low peak alpha frequency and diffuse, unstable posterior alpha may respond better to gentle posterior alpha stabilisation (Pz with O1/O2 montage options, training alpha amplitude or alpha coherence) paired with autonomic downshifting, rather than chasing symptom-driven frontal protocols on day one.
Second is the malleable state layer: features that fluctuate with arousal, attention, fatigue, medication timing, pain, and mood. In fingerprint language, these are the components that reduce within-person similarity across sessions. Clinically, they often show up as “today’s brain” versus “last week’s brain.” When I see that, it doesn’t mean the data are useless; it means the immediate training goal should be state control. That is where classic stabilizers do their best work: SMR training around 12–15 Hz at C3/C4 (or Cz, depending on presentation), theta/beta balancing when appropriate, and posterior alpha enhancement for overarousal and sleep onset difficulties. If the state layer is dominant, I prioritize protocols that reliably move the dial within a session and then test for carryover.
Third is the vulnerability layer: the features that are stable but maladaptive. This is where fingerprinting becomes clinically sharp. A person can have a highly identifiable brain pattern that is also a signature of rigidity—too much high beta in frontal networks, chronically reduced alpha modulation, or persistent connectivity patterns that mirror perseverative threat monitoring. In those cases, “responder” status may depend less on whether we can change the EEG at all (we usually can) and more on whether we can change the right piece without destabilizing everything else.
That’s the first big theme you asked for: using fingerprinting to pick protocols and identify responders and non-responders.
In an ideal near-future workflow, you would collect repeated baselines (even short ones) and compute something like differential identifiability for EEG features: which bands, which sites, which connectivity edges are stable and discriminative within a person. Then you would overlay clinical goals and choose targets that sit at the intersection of stability and relevance. If a client’s sensorimotor network features are the most reliable and their symptoms include impulsivity and sleep disruption, SMR at Cz or C4 becomes a principled starting point rather than a tradition. If a client’s most stable signature is a rigid fronto-limbic beta connectivity pattern alongside anxiety and rumination, a combination of frontal beta downtraining (Fz, sometimes F3/F4 depending on asymmetry and symptom profile) plus posterior alpha support may be more logical than immediately pursuing “performance” protocols.
Responder prediction may also become more realistic when we stop asking a single question (“Did the symptoms improve?”) and ask two: (1) can the nervous system learn, and (2) does the learned change land in a functionally helpful direction? Fingerprinting helps with the first. If a person’s within-session state shifts are clear but their between-session similarity keeps snapping back, that suggests learning is happening but consolidation is weak. Clinically, I interpret that as a cue to adjust dosage and context: shorter, more frequent sessions; stronger reinforcement schedules; pairing with HRV biofeedback for autonomic stability; and making sure sleep, stimulants, and stress are not sabotaging consolidation. If, instead, the EEG barely moves in-session and fingerprints are rigidly stable, that’s when I broaden the training channel: add peripheral biofeedback (respiration pace, HRV coherence, electrodermal downtraining), use engagement tools (multimodal feedback, task-based NF), and sometimes shift the target away from “change the trait” toward “increase flexibility around the trait.”
Now the second theme: measuring changes in fingerprints to show how neurofeedback shapes both states and traits.
One of the quiet problems in neurofeedback research is that we often measure outcomes at the wrong granularity. A pre/post symptom scale is too coarse to capture what training actually does in the brain: it first teaches state control (the person can enter a calmer, more focused mode on demand), then, with repetition, it can reshape trait-like tendencies (the calmer mode becomes more accessible, more default, and less expensive to maintain). Fingerprinting is built for separating those two.
State change is visible within sessions. You can quantify whether the EEG pattern during training becomes more “coherent” or more “stable” compared to baseline, whether the person’s alpha network becomes more organized during eyes-closed relaxation blocks, or whether SMR bursts become more frequent and less effortful. In fingerprint terms, you are watching the nervous system discover a reproducible configuration that it can return to. I’ve seen this in practice with clients who arrive dysregulated: the first sessions look messy, then suddenly there’s a day where posterior alpha locks in, respiration slows, shoulders drop, and the person says, “Oh—this is what calm feels like.” That moment is not the end point; it is the first successful retrieval of a state.
Trait change shows up across days and contexts. If you re-record resting EEG every five to ten sessions, you can ask: is the person’s baseline fingerprint drifting in a consistent direction, or is it only changing in the chair? For example, after a course of SMR training (12–15 Hz) at Cz/C4, a meaningful trait shift might look like a reduction in excessive theta during quiet wakefulness, improved stability of sensorimotor rhythms, and a more consistent connectivity pattern supporting inhibitory control. After posterior alpha training (often 8–12 Hz, individualized around the person’s peak alpha) at Pz/O1/O2, trait change might look like a more robust alpha peak, better alpha reactivity (suppression during task, rebound at rest), and reduced high-beta spillover.
The most compelling fingerprint story is when state and trait changes line up: the state you trained becomes the trait you measure. That alignment can also protect us from fooling ourselves. If symptoms improve but fingerprints show only random drift and poor test-retest reliability, we should be cautious about attributing the gains to neurofeedback rather than expectancy, regression to the mean, or unrelated life changes. Conversely, if fingerprints show stable, replicable shifts in targeted features but symptoms lag, that is not failure—it is often timing. The brain can learn before the person’s life catches up. In those cases, I lean into transfer: homework practices, cue-based self-regulation, and pairing training with psychotherapy so the new physiological capacity has somewhere to go.
There is also a subtler clinical advantage: fingerprints can help detect when we are training the wrong thing. If a protocol produces strong in-session changes but the person’s broader fingerprint becomes less stable, more noisy, or more context-fragile, it can be a sign that we are pushing arousal too hard, reinforcing a compensatory strategy, or ignoring a physiological constraint. This is where clinical practice differs from tidy research designs. Real clients bring medication changes, sleep debt, trauma triggers, and complex comorbidities. A fingerprint framework doesn’t eliminate that mess—it gives us a way to track it.
If I had to translate all of this into a practical rule for the clinic, it would be: train what is changeable, but measure what is stable. Use stable fingerprints to pick targets and verify durable change; use state metrics to guide session-by-session adjustments.
The irony is that fingerprinting also invites humility. A person’s brain signature is not a trophy to “normalize.” It is a living pattern shaped by development, learning, and adaptation. The goal of neurofeedback is not to erase uniqueness; it is to help the nervous system access a wider, healthier repertoire—calm when calm is needed, alert when alert is needed, flexible when life demands switching gears.
If brain fingerprinting becomes part of our toolkit, it could move the field away from protocol folklore and toward something closer to precision self-regulation: measurable individuality, thoughtful targets, and change that we can see not only in symptoms, but in the evolving signature of the brain itself.
Conclusion
Brain fingerprinting takes a familiar truth—no two brains are the same—and turns it into a measurement strategy. By treating interindividual variability as information, not error, it offers a framework for identifying people from connectivity patterns, clarifying what is stable within a person, and understanding how tasks, drugs, sleep, anesthesia, and disease can reshape neural uniqueness.
From a signal-processing perspective, the review highlights why this is more than a clever party trick. Choices about denoising, reliability, distance metrics, and model validation change what we call a “fingerprint,” and they determine whether findings will generalize outside a single scanner or lab.
For biofeedback and neurofeedback, the larger lesson is simple: personalization is not a luxury feature, it is the basic operating principle. The more precisely we can map what is stable and individual, the more intelligently we can choose training targets—and the more likely it is that self-regulation practice will translate into real-world change.
References
Preti, M. G., Van De Ville, D., & Amico, E. (2025). Brain fingerprinting: A signal processing perspective. IEEE Signal Processing Magazine, 91–102. https://doi.org/10.1109/MSP.2025.3615296